Log in to save to my catalogue

Astrocyte biomarkers GFAP and YKL‐40 mediate early Alzheimer's disease progression

Astrocyte biomarkers GFAP and YKL‐40 mediate early Alzheimer's disease progression

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_333004

Astrocyte biomarkers GFAP and YKL‐40 mediate early Alzheimer's disease progression

About this item

Full title

Astrocyte biomarkers GFAP and YKL‐40 mediate early Alzheimer's disease progression

Publisher

United States: John Wiley & Sons, Inc

Journal title

Alzheimer's & dementia, 2024-01, Vol.20 (1), p.483-493

Language

English

Formats

Publication information

Publisher

United States: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

INTRODUCTION
We studied how biomarkers of reactive astrogliosis mediate the pathogenic cascade in the earliest Alzheimer's disease (AD) stages.
METHODS
We performed path analysis on data from 384 cognitively unimpaired individuals from the ALzheimer and FAmilies (ALFA)+ study using structural equation modeling to quantify the relationships...

Alternative Titles

Full title

Astrocyte biomarkers GFAP and YKL‐40 mediate early Alzheimer's disease progression

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_gup_ub_gu_se_333004

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_333004

Other Identifiers

ISSN

1552-5260,1552-5279

E-ISSN

1552-5279

DOI

10.1002/alz.13450

How to access this item